ETFIQData as of Nov 13, 2026. · etfiq.com/funds/labu

LABU Fact Sheet: Direxion Daily S&P Biotech Bull 3X ETF

Share
$214.83
close, Nov 13, 2026

Over the year to Nov 13, 2026, LABU returned +70.3% in total and charged 0.96% a year.

1-year total return
+70.3%
XBI +35.1% to Nov 13, 2026
Expense ratio
0.96%
a year
Net assets
$540m
on Nov 12, 2026
Net flow, last 5 trading days
−$787k
daily basis to Nov 12, 2026

Growth of $10,000, 1 year

LABU $17,034 +70.3% · XBI $13,509 +35.1% · Total return, distributions reinvested, Nov 13, 2025 to Nov 13, 2026.

Returns

WindowTotal return
1 month+2.3%
3 months−22.3%
Year to date+34.8%
1 year+70.3%
3 years+238.0%

Total return, distributions reinvested, each window to Nov 13, 2026.

Facts

Aims to return three times the daily move of biotech (XBI) · First traded May 28, 2015 · Benchmark XBI

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, LABU Fact Sheet: Direxion Daily S&P Biotech Bull 3X ETF. Data as of Nov 13, 2026. https://etfiq.com/funds/labu/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/labu.